COMPARISON OF THE VALUE OF INFLAMMATION MARKERS AND HEART REMODELING PARAMETERS IN PATIENTS WITH DISTINCT TYPES OF ATRIAL FIBRILLATION

QR Code

COMPARISON OF THE VALUE OF INFLAMMATION MARKERS AND HEART REMODELING PARAMETERS IN PATIENTS WITH DISTINCT TYPES OF ATRIAL FIBRILLATION

Aim. To compare the influence of the most informative parameters of inflammatory markers and structural-geometrical parameters of the heart remodeling in patients with different clinical types of atrial fibrillation (AF). Material and methods. We observed 141 patients with ischemic heart disease (CH...

Full description

Saved in:

Bibliographic Details
Main Authors:	L. G. Azarapetyan, S. V. Grigoryan, K. G. Adamyan
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2015-06-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	atrial fibrillation inflammation c-reactive protein interleukine-6 heart remodeling
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/136
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparative evaluation of markers of inflammation and fibrosis in patients with various clinical forms of atrial fibrillation
by: S. V. Grigoryan, et al.
Published: (2018-12-01)

The role of inflammatory markers in atrial fibrillation: a review
by: S. V. Grigoryan, et al.
Published: (2012-10-01)

Biomarkers of inflammation, parameters characterizing obesity and cardiac remodeling in patients with atrial fibrillation and metabolic syndrome
by: V. A. Ionin, et al.
Published: (2021-04-01)

Myocardial fibrosis and atrial fibrillation
by: S. V. Grigoryan, et al.
Published: (2018-09-01)

Interactions between atrial fibrosis and inflammation in atrial fibrillation
by: Zhihua Pang, et al.
Published: (2025-07-01)

Atrial Fibrillation in Diabetes: Pathogenesis and Targeted Rhythm Control Strategies
by: Konstantinos Grigoriou, et al.
Published: (2025-07-01)

Atrial remodelling comparison after maze-3 and cryo-maze procedures in combined cardiac interventions: a retrospective study
by: G. N. Antipov, et al.
Published: (2022-05-01)

Left heart remodeling as a risk factor for atrial fibrillation in patients after surgery of acquired heart defects
by: I. I. Averina, et al.
Published: (2023-08-01)

Role of inflammatory markers in the pathogenesis and outcome of atrial fibrillation different clinical forms
by: K. G. Adamyan, et al.
Published: (2011-03-01)

ATRIAL FIBRILLATION AND ARTERIAL HYPERTENSION: GENDER DIFFERENCES OF VENTRICULOATRIAL REMODELING WITH PRESERVED EJECTION FRACTION
by: Zh. D. Kobalava, et al.
Published: (2017-09-01)

Biomarkers of fibrosis and inflammation and the risk of arrhythmia recurrence after elective electrical cardioversion in patients with atrial fibrillation and metabolic syndrome
by: E. I. Barashkova, et al.
Published: (2024-06-01)

Inflammation and atrial fibrillation
by: Yasushi Mukai
Published: (2024-02-01)

Quantitative analysis of fractionated electrogram area of left atrium during right atrial pacing as an indicator of left atrial electrical remodeling in patients with atrial fibrillation
by: Takayuki Sekihara, et al.
Published: (2024-02-01)

Inflammation role in atrial fibrillation pathogenesis
by: A. I. Tarzimanova, et al.
Published: (1970-01-01)

GENETIC POLYMORPHISM OF INFLAMMATORY FACTORS IS ASSOCIATED WITH THROMBOEMBOLIC COMPLICATIONS OF ATRIAL FIBRILLATION
by: I. V. Zotova, et al.
Published: (2015-10-01)

Effect of CPAP therapy on left atrial remodeling in patients with paroxysmal atrial fibrillation and obstructive sleep apnea undergoing pulmonary vein isolation
by: A. G. Topchyan, et al.
Published: (2022-08-01)

Inotropic myocardial function dynamics in patients with recurrent atrial fibrillation
by: N. E. Gaidamakina, et al.
Published: (2006-06-01)

Reverse remodeling against the background of cardiac contractility modulation therapy in patients with heart failure and atrial fibrillation
by: A. A. Safiullina, et al.
Published: (2022-02-01)

Divergent Cardiac Adaptations in Endurance Sport: Atrial Fibrillation Markers in Marathon Versus Ultramarathon Athletes
by: Zbigniew Waśkiewicz, et al.
Published: (2025-07-01)

Pathogenic Mechanisms of Atrial Fibrillation in Obesity
by: O. M. Drapkina, et al.
Published: (2016-11-01)

Atrial Fibrillation: Development Mechanisms, Approaches and Prospects of Therapy
by: O. V. Sapelnikov, et al.
Published: (2020-03-01)

Comparative characteristics of patients with a combination of obstructive sleep apnea and paroxysmal atrial fibrillation in the groups of interventional and conservative treatment of arrhythmia
by: N. T. Obukhova, et al.
Published: (2024-08-01)

Gender differences in serum markers of inflammation and platelet activation in patients with non-valvular atrial fibrillation
by: O. N. Ogurkova, et al.
Published: (2023-06-01)

Patterns of structural and functional remodeling of the left ventricle in patients with various forms of atrial fibrillation
by: A. I. Kochetkov, et al.
Published: (2024-04-01)

Impact of Surgical Ablation of Atrial Fibrillation on the Progression of Tricuspid Regurgitation and Right‐Sided Heart Remodeling After Mitral‐Valve Surgery: A Propensity‐Score Matching Analysis
by: Jiangang Wang, et al.
Published: (2016-12-01)

Cardiopulmonary factors associated with atrial fibrillation in patients with chronic obstructive pulmonary disease
by: E. I. Leonova, et al.
Published: (2017-01-01)

Cardiopulmonary factors associated with atrial fibrillation in patients with chronic obstructive pulmonary disease
by: E. I. Leonova, et al.
Published: (2016-03-01)

Molecular mechanisms of the development of atrial fibrillation in patients with type 2 diabetes mellitus: prognostic role of biomarkers of fibrosis and inflammation
by: V. A. Ionin, et al.
Published: (2022-11-01)

Atrial Fibrillation: a Marker or Risk Factor for Stroke
by: B. A. Tatarsky, et al.
Published: (2023-03-01)

Left Atrial Remodeling Identification and Catheter Ablation Outcomes With 18F‐Fluorodeoxyglucose Positron Emission Tomography in Persistent Atrial Fibrillation
by: Tristan Raoult, et al.
Published: (2025-07-01)

ELECTRO-MECHANICAL HEART REMODELLING AND ATRIAL FIBRILLATION DEVELOPMENT IN PATIENTS WITH CORONARY HEART DISEASE AND ARTERIAL HYPERTENSION
by: D. V. Dedov, et al.
Published: (2011-08-01)

The role of inflammatory theory in the pathogenesis of atrial fibrillation
by: K. V. Davtyan, et al.
Published: (2019-08-01)

Propafenone effect on inotropic myocardial function in patients with recurrent atral fibrillation
by: I. G. Fomina, et al.
Published: (2006-06-01)

Predictors of paroxysmal thyrotoxic atrial fibrillation
by: L. N. Berestennikova, et al.
Published: (2011-10-01)

CLINICAL ANALYSIS OF ASSOCIATION OF CYSTATIN C AND ATRIAL FIBRILLATION
by: Ping Liu, et al.
Published: (2014-07-01)

CLINICAL ANALYSIS OF ASSOCIATION OF CYSTATIN C AND ATRIAL FIBRILLATION
by: Ping Liu, et al.
Published: (2014-04-01)

Molecular genetic markers of atrial fibrillation
by: A. V. Ponasenko, et al.
Published: (2020-04-01)

Βeta-adrenergic receptor reactivity of erythrocyte membranes in patients with left or right atrial dilatation against the background of atrial fibrillation
by: E. F. Muslimova, et al.
Published: (2023-10-01)

THE EFFECT OF ALDOSTERONE ANTAGONISTS ON THE ELECTROPHYSIOLOGICAL PARAMETERS IN RECURRENCE ATRIAL FIBRILLATION
by: N. T. Vatutin, et al.
Published: (2016-09-01)

Endothelial activation, cell-cell interactions, and inflammatory pathways in postoperative atrial fibrillation following cardiac surgery
by: Raquel López-Gálvez, et al.
Published: (2025-08-01)